nodes	percent_of_prediction	percent_of_DWPC	metapath
Dasatinib—MYT1—brain—conduct disorder	0.0269	0.057	CbGeAlD
Dasatinib—EPHB1—brain—conduct disorder	0.0179	0.038	CbGeAlD
Dasatinib—SIK2—brain—conduct disorder	0.0158	0.0336	CbGeAlD
Dasatinib—PKMYT1—brain—conduct disorder	0.0154	0.0327	CbGeAlD
Dasatinib—EPHB2—brain—conduct disorder	0.0147	0.0312	CbGeAlD
Dasatinib—SRMS—brain—conduct disorder	0.0144	0.0306	CbGeAlD
Dasatinib—EPHA8—brain—conduct disorder	0.0141	0.0299	CbGeAlD
Dasatinib—STAT5B—brain—conduct disorder	0.0133	0.0283	CbGeAlD
Dasatinib—EPHA3—brain—conduct disorder	0.0123	0.0262	CbGeAlD
Dasatinib—SIK3—brain—conduct disorder	0.012	0.0255	CbGeAlD
Dasatinib—ZAK—brain—conduct disorder	0.0112	0.0237	CbGeAlD
Dasatinib—EPHA5—brain—conduct disorder	0.0109	0.0232	CbGeAlD
Dasatinib—LYN—brain—conduct disorder	0.0109	0.023	CbGeAlD
Dasatinib—MAP3K19—brain—conduct disorder	0.0107	0.0227	CbGeAlD
Dasatinib—BMPR1B—brain—conduct disorder	0.0107	0.0227	CbGeAlD
Dasatinib—BTK—brain—conduct disorder	0.0106	0.0226	CbGeAlD
Dasatinib—TNK2—brain—conduct disorder	0.0105	0.0223	CbGeAlD
Dasatinib—TESK1—brain—conduct disorder	0.00986	0.0209	CbGeAlD
Dasatinib—STK36—brain—conduct disorder	0.0097	0.0206	CbGeAlD
Dasatinib—EPHB3—brain—conduct disorder	0.0097	0.0206	CbGeAlD
Dasatinib—LIMK2—brain—conduct disorder	0.00938	0.0199	CbGeAlD
Dasatinib—STK35—brain—conduct disorder	0.00909	0.0193	CbGeAlD
Dasatinib—CSK—brain—conduct disorder	0.00903	0.0192	CbGeAlD
Dasatinib—HCK—brain—conduct disorder	0.00892	0.0189	CbGeAlD
Dasatinib—ABL2—brain—conduct disorder	0.00886	0.0188	CbGeAlD
Dasatinib—RIPK2—brain—conduct disorder	0.00838	0.0178	CbGeAlD
Dasatinib—SIK1—brain—conduct disorder	0.00819	0.0174	CbGeAlD
Dasatinib—EPHA4—brain—conduct disorder	0.0081	0.0172	CbGeAlD
Dasatinib—ERBB3—brain—conduct disorder	0.00803	0.017	CbGeAlD
Dasatinib—MAP3K2—brain—conduct disorder	0.00795	0.0169	CbGeAlD
Dasatinib—MAPK14—brain—conduct disorder	0.00747	0.0159	CbGeAlD
Dasatinib—FGR—brain—conduct disorder	0.00744	0.0158	CbGeAlD
Dasatinib—FMO3—brain—conduct disorder	0.00719	0.0153	CbGeAlD
Dasatinib—EPHB4—brain—conduct disorder	0.00708	0.015	CbGeAlD
Dasatinib—JAK2—brain—conduct disorder	0.00703	0.0149	CbGeAlD
Dasatinib—EPHA2—brain—conduct disorder	0.00695	0.0147	CbGeAlD
Dasatinib—FYN—brain—conduct disorder	0.00694	0.0147	CbGeAlD
Dasatinib—MAP4K5—brain—conduct disorder	0.00678	0.0144	CbGeAlD
Dasatinib—MAP3K3—brain—conduct disorder	0.00678	0.0144	CbGeAlD
Dasatinib—EPHB6—brain—conduct disorder	0.00648	0.0137	CbGeAlD
Dasatinib—YES1—brain—conduct disorder	0.00626	0.0133	CbGeAlD
Dasatinib—PDGFRA—brain—conduct disorder	0.00614	0.013	CbGeAlD
Dasatinib—SRC—brain—conduct disorder	0.00602	0.0128	CbGeAlD
Dasatinib—MAP2K5—brain—conduct disorder	0.00554	0.0118	CbGeAlD
Dasatinib—CSF1R—brain—conduct disorder	0.00541	0.0115	CbGeAlD
Dasatinib—KIT—brain—conduct disorder	0.00491	0.0104	CbGeAlD
Dasatinib—PDGFRB—brain—conduct disorder	0.0048	0.0102	CbGeAlD
Dasatinib—ABL1—brain—conduct disorder	0.00427	0.00907	CbGeAlD
Dasatinib—CYP1B1—brain—conduct disorder	0.00362	0.00768	CbGeAlD
Dasatinib—ABCG2—brain—conduct disorder	0.0027	0.00572	CbGeAlD
Dasatinib—CYP1A1—brain—conduct disorder	0.00256	0.00543	CbGeAlD
Dasatinib—ABCB1—brain—conduct disorder	0.00133	0.00282	CbGeAlD
Dasatinib—SRC—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.000621	0.00117	CbGpPWpGaD
Dasatinib—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.000619	0.00117	CbGpPWpGaD
Dasatinib—KIT—Immune System—POLR3A—conduct disorder	0.000617	0.00117	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—CGA—conduct disorder	0.00061	0.00115	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—WASF1—conduct disorder	0.00061	0.00115	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—CGA—conduct disorder	0.000606	0.00115	CbGpPWpGaD
Dasatinib—CYP1A1—Biological oxidations—COMT—conduct disorder	0.000593	0.00112	CbGpPWpGaD
Dasatinib—CYP1A1—Biological oxidations—MAOA—conduct disorder	0.000589	0.00111	CbGpPWpGaD
Dasatinib—CYP1A1—Metapathway biotransformation—COMT—conduct disorder	0.000585	0.00111	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—POLR3A—conduct disorder	0.000584	0.0011	CbGpPWpGaD
Dasatinib—SRC—Androgen receptor signaling pathway—EP300—conduct disorder	0.000582	0.0011	CbGpPWpGaD
Dasatinib—YES1—Immune System—WASF1—conduct disorder	0.000581	0.0011	CbGpPWpGaD
Dasatinib—PKMYT1—Cell Cycle—EP300—conduct disorder	0.000577	0.00109	CbGpPWpGaD
Dasatinib—LCK—Immune System—MB21D1—conduct disorder	0.000575	0.00109	CbGpPWpGaD
Dasatinib—ABL2—Developmental Biology—EP300—conduct disorder	0.000574	0.00109	CbGpPWpGaD
Dasatinib—EPHA3—Developmental Biology—EP300—conduct disorder	0.000574	0.00109	CbGpPWpGaD
Dasatinib—EPHA5—Developmental Biology—EP300—conduct disorder	0.000574	0.00109	CbGpPWpGaD
Dasatinib—ABL1—Factors involved in megakaryocyte development and platelet production—EP300—conduct disorder	0.000568	0.00108	CbGpPWpGaD
Dasatinib—MAPK14—TGF-beta Signaling Pathway—EP300—conduct disorder	0.000554	0.00105	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—CGA—conduct disorder	0.000554	0.00105	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—CGA—conduct disorder	0.000554	0.00105	CbGpPWpGaD
Dasatinib—EPHA8—Developmental Biology—EP300—conduct disorder	0.000553	0.00105	CbGpPWpGaD
Dasatinib—LIMK2—Developmental Biology—EP300—conduct disorder	0.000547	0.00104	CbGpPWpGaD
Dasatinib—EPHB4—Developmental Biology—EP300—conduct disorder	0.000547	0.00104	CbGpPWpGaD
Dasatinib—EPHA4—Developmental Biology—EP300—conduct disorder	0.000547	0.00104	CbGpPWpGaD
Dasatinib—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000546	0.00103	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—WASF1—conduct disorder	0.00054	0.00102	CbGpPWpGaD
Dasatinib—JAK2—Factors involved in megakaryocyte development and platelet production—EP300—conduct disorder	0.000534	0.00101	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—CGA—conduct disorder	0.000534	0.00101	CbGpPWpGaD
Dasatinib—EPHB2—Developmental Biology—EP300—conduct disorder	0.00053	0.001	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—POLR3A—conduct disorder	0.000526	0.000995	CbGpPWpGaD
Dasatinib—ABL1—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.000523	0.000989	CbGpPWpGaD
Dasatinib—KIT—Immune System—WASF1—conduct disorder	0.000519	0.000982	CbGpPWpGaD
Dasatinib—LYN—Immune System—POLR3A—conduct disorder	0.000515	0.000974	CbGpPWpGaD
Dasatinib—EPHB6—Developmental Biology—EP300—conduct disorder	0.000515	0.000973	CbGpPWpGaD
Dasatinib—ABL1—Immune System—POLR3A—conduct disorder	0.000512	0.000969	CbGpPWpGaD
Dasatinib—SRC—Immune System—MB21D1—conduct disorder	0.000509	0.000963	CbGpPWpGaD
Dasatinib—FYN—Immune System—POLR3A—conduct disorder	0.000507	0.000959	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000505	0.000954	CbGpPWpGaD
Dasatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000493	0.000933	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—WASF1—conduct disorder	0.000491	0.000929	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—POLR3A—conduct disorder	0.000488	0.000923	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—WASF1—conduct disorder	0.000486	0.000918	CbGpPWpGaD
Dasatinib—MAPK14—Gene Expression—POLR3A—conduct disorder	0.000485	0.000918	CbGpPWpGaD
Dasatinib—JAK2—Immune System—POLR3A—conduct disorder	0.000482	0.000911	CbGpPWpGaD
Dasatinib—CSK—Hemostasis—EP300—conduct disorder	0.000479	0.000905	CbGpPWpGaD
Dasatinib—SRMS—Immune System—EP300—conduct disorder	0.00047	0.000889	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—DRD4—conduct disorder	0.000469	0.000888	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—CGA—conduct disorder	0.000469	0.000887	CbGpPWpGaD
Dasatinib—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.000466	0.000881	CbGpPWpGaD
Dasatinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000466	0.000881	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—DRD4—conduct disorder	0.000455	0.00086	CbGpPWpGaD
Dasatinib—EPHA2—Developmental Biology—EP300—conduct disorder	0.000446	0.000844	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—WASF1—conduct disorder	0.000444	0.00084	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—WASF1—conduct disorder	0.000443	0.000837	CbGpPWpGaD
Dasatinib—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.000437	0.000827	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—HTR2A—conduct disorder	0.000435	0.000822	CbGpPWpGaD
Dasatinib—LYN—Immune System—WASF1—conduct disorder	0.000433	0.00082	CbGpPWpGaD
Dasatinib—ABL1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000433	0.000819	CbGpPWpGaD
Dasatinib—ABL1—Immune System—WASF1—conduct disorder	0.000431	0.000816	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—WASF1—conduct disorder	0.000428	0.00081	CbGpPWpGaD
Dasatinib—FYN—Immune System—WASF1—conduct disorder	0.000427	0.000807	CbGpPWpGaD
Dasatinib—SRC—TGF-beta Signaling Pathway—EP300—conduct disorder	0.000424	0.000803	CbGpPWpGaD
Dasatinib—LCK—Immune System—POLR3A—conduct disorder	0.000422	0.000798	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—CGA—conduct disorder	0.000419	0.000792	CbGpPWpGaD
Dasatinib—MAPK14—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000413	0.00078	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—WASF1—conduct disorder	0.000411	0.000777	CbGpPWpGaD
Dasatinib—JAK2—Immune System—WASF1—conduct disorder	0.000406	0.000767	CbGpPWpGaD
Dasatinib—TXK—Immune System—EP300—conduct disorder	0.0004	0.000756	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—CGA—conduct disorder	0.000396	0.00075	CbGpPWpGaD
Dasatinib—CYP1A2—Biological oxidations—COMT—conduct disorder	0.000378	0.000715	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—WASF1—conduct disorder	0.000376	0.000711	CbGpPWpGaD
Dasatinib—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.000376	0.00071	CbGpPWpGaD
Dasatinib—SRC—Immune System—POLR3A—conduct disorder	0.000374	0.000707	CbGpPWpGaD
Dasatinib—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.000373	0.000706	CbGpPWpGaD
Dasatinib—JAK2—Chromatin modifying enzymes—EP300—conduct disorder	0.000368	0.000696	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—COMT—conduct disorder	0.000367	0.000694	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—CGA—conduct disorder	0.000365	0.00069	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—MAOA—conduct disorder	0.000364	0.000689	CbGpPWpGaD
Dasatinib—CYP1A1—PPARA activates gene expression—EP300—conduct disorder	0.000364	0.000688	CbGpPWpGaD
Dasatinib—BTK—Innate Immune System—EP300—conduct disorder	0.00036	0.000682	CbGpPWpGaD
Dasatinib—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000359	0.00068	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—CGA—conduct disorder	0.000357	0.000675	CbGpPWpGaD
Dasatinib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.000356	0.000673	CbGpPWpGaD
Dasatinib—LCK—Immune System—WASF1—conduct disorder	0.000355	0.000672	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—CGA—conduct disorder	0.00035	0.000661	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—CGA—conduct disorder	0.000344	0.000651	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—DRD4—conduct disorder	0.000342	0.000646	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—DRD4—conduct disorder	0.000339	0.000642	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—WASF1—conduct disorder	0.000336	0.000635	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—CGA—conduct disorder	0.000332	0.000628	CbGpPWpGaD
Dasatinib—FGR—Hemostasis—EP300—conduct disorder	0.000332	0.000627	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—CGA—conduct disorder	0.000331	0.000627	CbGpPWpGaD
Dasatinib—HCK—Innate Immune System—EP300—conduct disorder	0.000331	0.000625	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—CGA—conduct disorder	0.000327	0.000619	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000322	0.000609	CbGpPWpGaD
Dasatinib—MAPK14—Cellular responses to stress—EP300—conduct disorder	0.000318	0.000602	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—WASF1—conduct disorder	0.000318	0.000601	CbGpPWpGaD
Dasatinib—SRC—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000316	0.000597	CbGpPWpGaD
Dasatinib—SRC—Immune System—WASF1—conduct disorder	0.000314	0.000595	CbGpPWpGaD
Dasatinib—RIPK2—Innate Immune System—EP300—conduct disorder	0.000311	0.000589	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—DRD4—conduct disorder	0.00031	0.000587	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—DRD4—conduct disorder	0.00031	0.000587	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—HTR2A—conduct disorder	0.000306	0.000579	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—DRD4—conduct disorder	0.000299	0.000566	CbGpPWpGaD
Dasatinib—FGR—Innate Immune System—EP300—conduct disorder	0.000299	0.000565	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—HTR2A—conduct disorder	0.000297	0.000561	CbGpPWpGaD
Dasatinib—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000292	0.000552	CbGpPWpGaD
Dasatinib—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00029	0.000548	CbGpPWpGaD
Dasatinib—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.000288	0.000545	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—CGA—conduct disorder	0.000287	0.000542	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—WASF1—conduct disorder	0.000286	0.000541	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—WASF1—conduct disorder	0.00028	0.00053	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—WASF1—conduct disorder	0.000276	0.000522	CbGpPWpGaD
Dasatinib—ERBB3—Innate Immune System—EP300—conduct disorder	0.000275	0.000519	CbGpPWpGaD
Dasatinib—YES1—Developmental Biology—EP300—conduct disorder	0.000273	0.000516	CbGpPWpGaD
Dasatinib—YES1—Hemostasis—EP300—conduct disorder	0.000268	0.000506	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—WASF1—conduct disorder	0.000266	0.000502	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—DRD4—conduct disorder	0.000263	0.000497	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—WASF1—conduct disorder	0.000262	0.000496	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—CGA—conduct disorder	0.000254	0.00048	CbGpPWpGaD
Dasatinib—CSK—Immune System—EP300—conduct disorder	0.000251	0.000475	CbGpPWpGaD
Dasatinib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.000245	0.000464	CbGpPWpGaD
Dasatinib—STAT5B—Immune System—EP300—conduct disorder	0.000243	0.00046	CbGpPWpGaD
Dasatinib—YES1—Innate Immune System—EP300—conduct disorder	0.000241	0.000456	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—CGA—conduct disorder	0.000238	0.00045	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—DRD4—conduct disorder	0.000234	0.000444	CbGpPWpGaD
Dasatinib—CSK—Disease—EP300—conduct disorder	0.000232	0.000438	CbGpPWpGaD
Dasatinib—BMPR1B—Signaling Pathways—EP300—conduct disorder	0.00023	0.000435	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—WASF1—conduct disorder	0.00023	0.000434	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—CGA—conduct disorder	0.000225	0.000425	CbGpPWpGaD
Dasatinib—STAT5B—Disease—EP300—conduct disorder	0.000224	0.000424	CbGpPWpGaD
Dasatinib—JAK2—GPCR downstream signaling—HTR2A—conduct disorder	0.000223	0.000421	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—DRD4—conduct disorder	0.000222	0.00042	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—HTR2A—conduct disorder	0.000221	0.000419	CbGpPWpGaD
Dasatinib—MAP3K3—Immune System—EP300—conduct disorder	0.000216	0.000408	CbGpPWpGaD
Dasatinib—KIT—Innate Immune System—EP300—conduct disorder	0.000215	0.000407	CbGpPWpGaD
Dasatinib—BTK—Immune System—EP300—conduct disorder	0.00021	0.000397	CbGpPWpGaD
Dasatinib—PDGFRA—Innate Immune System—EP300—conduct disorder	0.000204	0.000385	CbGpPWpGaD
Dasatinib—LYN—Developmental Biology—EP300—conduct disorder	0.000203	0.000385	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—WASF1—conduct disorder	0.000203	0.000385	CbGpPWpGaD
Dasatinib—ABL1—Developmental Biology—EP300—conduct disorder	0.000203	0.000383	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—HTR2A—conduct disorder	0.000202	0.000383	CbGpPWpGaD
Dasatinib—JAK2—Signaling by GPCR—HTR2A—conduct disorder	0.000202	0.000383	CbGpPWpGaD
Dasatinib—FYN—Developmental Biology—EP300—conduct disorder	0.0002	0.000379	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—DRD4—conduct disorder	0.0002	0.000378	CbGpPWpGaD
Dasatinib—LYN—Hemostasis—EP300—conduct disorder	0.0002	0.000378	CbGpPWpGaD
Dasatinib—ABL1—Hemostasis—EP300—conduct disorder	0.000199	0.000376	CbGpPWpGaD
Dasatinib—FYN—Hemostasis—EP300—conduct disorder	0.000197	0.000372	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—DRD4—conduct disorder	0.000196	0.00037	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—HTR2A—conduct disorder	0.000195	0.000369	CbGpPWpGaD
Dasatinib—MAPK14—Developmental Biology—EP300—conduct disorder	0.000193	0.000365	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—DRD4—conduct disorder	0.000193	0.000365	CbGpPWpGaD
Dasatinib—HCK—Immune System—EP300—conduct disorder	0.000193	0.000364	CbGpPWpGaD
Dasatinib—JAK2—Developmental Biology—EP300—conduct disorder	0.00019	0.00036	CbGpPWpGaD
Dasatinib—MAPK14—Hemostasis—EP300—conduct disorder	0.000189	0.000358	CbGpPWpGaD
Dasatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000187	0.000353	CbGpPWpGaD
Dasatinib—JAK2—Hemostasis—EP300—conduct disorder	0.000187	0.000353	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—DRD4—conduct disorder	0.000186	0.000351	CbGpPWpGaD
Dasatinib—PDGFRB—Innate Immune System—EP300—conduct disorder	0.000184	0.000347	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—DRD4—conduct disorder	0.000183	0.000347	CbGpPWpGaD
Dasatinib—RIPK2—Immune System—EP300—conduct disorder	0.000181	0.000343	CbGpPWpGaD
Dasatinib—LYN—Innate Immune System—EP300—conduct disorder	0.00018	0.00034	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—CGA—conduct disorder	0.000179	0.000339	CbGpPWpGaD
Dasatinib—ABL1—Innate Immune System—EP300—conduct disorder	0.000179	0.000338	CbGpPWpGaD
Dasatinib—HCK—Disease—EP300—conduct disorder	0.000178	0.000336	CbGpPWpGaD
Dasatinib—FYN—Innate Immune System—EP300—conduct disorder	0.000177	0.000335	CbGpPWpGaD
Dasatinib—BLK—Immune System—EP300—conduct disorder	0.000174	0.00033	CbGpPWpGaD
Dasatinib—FGR—Immune System—EP300—conduct disorder	0.000174	0.000329	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—HTR2A—conduct disorder	0.000171	0.000324	CbGpPWpGaD
Dasatinib—MAPK14—Innate Immune System—EP300—conduct disorder	0.00017	0.000322	CbGpPWpGaD
Dasatinib—JAK2—Innate Immune System—EP300—conduct disorder	0.000168	0.000318	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—COMT—conduct disorder	0.000165	0.000312	CbGpPWpGaD
Dasatinib—LCK—Hemostasis—EP300—conduct disorder	0.000164	0.000309	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—MAOA—conduct disorder	0.000164	0.000309	CbGpPWpGaD
Dasatinib—CSK—Signaling Pathways—EP300—conduct disorder	0.000162	0.000307	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—DRD4—conduct disorder	0.00016	0.000304	CbGpPWpGaD
Dasatinib—ERBB3—Immune System—EP300—conduct disorder	0.00016	0.000302	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000159	0.0003	CbGpPWpGaD
Dasatinib—FMO3—Metabolism—EP300—conduct disorder	0.000157	0.000298	CbGpPWpGaD
Dasatinib—STAT5B—Signaling Pathways—EP300—conduct disorder	0.000157	0.000297	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—HTR2A—conduct disorder	0.000153	0.000289	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—COMT—conduct disorder	0.00015	0.000283	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—MAOA—conduct disorder	0.000149	0.000281	CbGpPWpGaD
Dasatinib—SRC—Developmental Biology—EP300—conduct disorder	0.000148	0.000279	CbGpPWpGaD
Dasatinib—ERBB3—Disease—EP300—conduct disorder	0.000148	0.000279	CbGpPWpGaD
Dasatinib—LCK—Innate Immune System—EP300—conduct disorder	0.000147	0.000279	CbGpPWpGaD
Dasatinib—SRC—Hemostasis—EP300—conduct disorder	0.000145	0.000274	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—HTR2A—conduct disorder	0.000145	0.000274	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—CGA—conduct disorder	0.000143	0.000271	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—DRD4—conduct disorder	0.000142	0.000269	CbGpPWpGaD
Dasatinib—YES1—Immune System—EP300—conduct disorder	0.00014	0.000266	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—HTR2A—conduct disorder	0.00013	0.000247	CbGpPWpGaD
Dasatinib—SRC—Innate Immune System—EP300—conduct disorder	0.00013	0.000247	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—HTR2A—conduct disorder	0.000128	0.000242	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—HTR2A—conduct disorder	0.000126	0.000238	CbGpPWpGaD
Dasatinib—KIT—Immune System—EP300—conduct disorder	0.000125	0.000237	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—HTR2A—conduct disorder	0.000121	0.000229	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—HTR2A—conduct disorder	0.00012	0.000226	CbGpPWpGaD
Dasatinib—PDGFRA—Immune System—EP300—conduct disorder	0.000119	0.000224	CbGpPWpGaD
Dasatinib—RIPK2—Signaling Pathways—EP300—conduct disorder	0.000117	0.000222	CbGpPWpGaD
Dasatinib—KIT—Disease—EP300—conduct disorder	0.000116	0.000219	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—CGA—conduct disorder	0.000111	0.000209	CbGpPWpGaD
Dasatinib—PDGFRA—Disease—EP300—conduct disorder	0.00011	0.000207	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—COMT—conduct disorder	0.000107	0.000203	CbGpPWpGaD
Dasatinib—MAP2K5—Signaling Pathways—EP300—conduct disorder	0.000107	0.000203	CbGpPWpGaD
Dasatinib—PDGFRB—Immune System—EP300—conduct disorder	0.000107	0.000202	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—MAOA—conduct disorder	0.000107	0.000202	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—HTR2A—conduct disorder	0.000105	0.000198	CbGpPWpGaD
Dasatinib—LYN—Immune System—EP300—conduct disorder	0.000105	0.000198	CbGpPWpGaD
Dasatinib—ABL1—Immune System—EP300—conduct disorder	0.000104	0.000197	CbGpPWpGaD
Dasatinib—ERBB3—Signaling Pathways—EP300—conduct disorder	0.000103	0.000196	CbGpPWpGaD
Dasatinib—FYN—Immune System—EP300—conduct disorder	0.000103	0.000195	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—COMT—conduct disorder	0.000101	0.000192	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—MAOA—conduct disorder	0.000101	0.000191	CbGpPWpGaD
Dasatinib—MAPK14—Immune System—EP300—conduct disorder	9.92e-05	0.000188	CbGpPWpGaD
Dasatinib—PDGFRB—Disease—EP300—conduct disorder	9.87e-05	0.000187	CbGpPWpGaD
Dasatinib—JAK2—Immune System—EP300—conduct disorder	9.8e-05	0.000185	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	9.77e-05	0.000185	CbGpPWpGaD
Dasatinib—FYN—Disease—EP300—conduct disorder	9.51e-05	0.00018	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—HTR2A—conduct disorder	9.27e-05	0.000175	CbGpPWpGaD
Dasatinib—YES1—Signaling Pathways—EP300—conduct disorder	9.08e-05	0.000172	CbGpPWpGaD
Dasatinib—JAK2—Disease—EP300—conduct disorder	9.04e-05	0.000171	CbGpPWpGaD
Dasatinib—LCK—Immune System—EP300—conduct disorder	8.58e-05	0.000162	CbGpPWpGaD
Dasatinib—KIT—Signaling Pathways—EP300—conduct disorder	8.11e-05	0.000153	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—COMT—conduct disorder	8.1e-05	0.000153	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—MAOA—conduct disorder	8.05e-05	0.000152	CbGpPWpGaD
Dasatinib—LCK—Disease—EP300—conduct disorder	7.92e-05	0.00015	CbGpPWpGaD
Dasatinib—PDGFRA—Signaling Pathways—EP300—conduct disorder	7.67e-05	0.000145	CbGpPWpGaD
Dasatinib—SRC—Immune System—EP300—conduct disorder	7.6e-05	0.000144	CbGpPWpGaD
Dasatinib—CYP1B1—Metabolism—EP300—conduct disorder	7.06e-05	0.000134	CbGpPWpGaD
Dasatinib—SRC—Disease—EP300—conduct disorder	7.01e-05	0.000133	CbGpPWpGaD
Dasatinib—PDGFRB—Signaling Pathways—EP300—conduct disorder	6.91e-05	0.000131	CbGpPWpGaD
Dasatinib—LYN—Signaling Pathways—EP300—conduct disorder	6.77e-05	0.000128	CbGpPWpGaD
Dasatinib—FYN—Signaling Pathways—EP300—conduct disorder	6.66e-05	0.000126	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—COMT—conduct disorder	6.47e-05	0.000122	CbGpPWpGaD
Dasatinib—ABCG2—Metabolism—EP300—conduct disorder	6.43e-05	0.000122	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—MAOA—conduct disorder	6.42e-05	0.000121	CbGpPWpGaD
Dasatinib—MAPK14—Signaling Pathways—EP300—conduct disorder	6.42e-05	0.000121	CbGpPWpGaD
Dasatinib—JAK2—Signaling Pathways—EP300—conduct disorder	6.33e-05	0.00012	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	6.23e-05	0.000118	CbGpPWpGaD
Dasatinib—LCK—Signaling Pathways—EP300—conduct disorder	5.55e-05	0.000105	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—COMT—conduct disorder	4.99e-05	9.44e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—MAOA—conduct disorder	4.96e-05	9.38e-05	CbGpPWpGaD
Dasatinib—SRC—Signaling Pathways—EP300—conduct disorder	4.91e-05	9.29e-05	CbGpPWpGaD
Dasatinib—CYP3A5—Metabolism—EP300—conduct disorder	4.6e-05	8.71e-05	CbGpPWpGaD
Dasatinib—CYP1A1—Metabolism—EP300—conduct disorder	4.35e-05	8.23e-05	CbGpPWpGaD
Dasatinib—ABCB1—Metabolism—EP300—conduct disorder	3.47e-05	6.57e-05	CbGpPWpGaD
Dasatinib—CYP1A2—Metabolism—EP300—conduct disorder	2.77e-05	5.25e-05	CbGpPWpGaD
Dasatinib—CYP3A4—Metabolism—EP300—conduct disorder	2.14e-05	4.05e-05	CbGpPWpGaD
